CD274 and neoplasm: This allows us to distinguish PD-L1+ tumor cells, PD-L1− tumor cells, PD-L1+ immune cells within the tumor regions, and PD-L1+ immune cells within the non-tumor regions for final CPS calculation (Supplementary Figure S1).